Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) EPS (Basic): 2023-2025

Historic EPS (Basic) for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to -$1.22.

  • Zenas BioPharma's EPS (Basic) rose 75.70% to -$1.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.67, marking a year-over-year increase of 121.64%. This contributed to the annual value of -$11.89 for FY2024, which is 50.97% up from last year.
  • Per Zenas BioPharma's latest filing, its EPS (Basic) stood at -$1.22 for Q3 2025, which was up 2.40% from -$1.25 recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's EPS (Basic) registered a high of $16.94 during Q4 2024, and its lowest value of -$24.23 during Q2 2024.
  • Moreover, its 3-year median value for EPS (Basic) was -$1.25 (2025), whereas its average is -$5.23.
  • Over the last 5 years, Zenas BioPharma's EPS (Basic) had its largest YoY gain of 205.61% in 2024, and its largest YoY loss of 307.44% in 2024.
  • Zenas BioPharma's EPS (Basic) (Quarterly) stood at -$16.04 in 2023, then soared by 205.61% to $16.94 in 2024, then surged by 75.70% to -$1.22 in 2025.
  • Its EPS (Basic) stands at -$1.22 for Q3 2025, versus -$1.25 for Q2 2025 and -$0.80 for Q1 2025.